Production of a new hybrid anthracycline 4-O-methylepelmycin by heterologous expression of dnrK in epelmycin-producing Streptomyces violaceus

Journal of Antibiotics

Volumn 53, Issue 8, 2000, Pages 828-836

  Miyamoto, Y ^a   Ohta, S ^a   Johdo, O ^a   Nagamatsu, Y ^a   Yoshimoto, A ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLEPELMYCIN D; 7 O LEVORHODOSAMINYL 4 O METHYL EPSILON RHODOMYCINONE; ACLARUBICIN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CARUBICIN; D 788 5; D 788 6; EPELMYCIN D; METHYLTRANSFERASE; N,N DIDEMETHYL 4 O DEMETHYLEPELMYCIN D; N,N DIDEMETHYL 4 O METHYLEPELMYCIN D; THIOSTREPTON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; GENETIC CODE; HYBRID; LEUKEMIA L 1210; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES;

STREPTOMYCES PEUCETIUS; STREPTOMYCES VIOLACEUS;

EID: 0033863774     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.828     Document Type: Article

References (24)

1. Daunomycin, an antitumor antibiotic in treatment of neoplastic disease
2. Adriamycin (NSC-123, 127): A new antibiotic with antitumor activity
3. Aclarubicin and pirarubicin: Basic research
4. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262
5. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hyroxaclacinomycins A and B by a recombinant strain and their antitumor activities
6. Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant
7. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788
8. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant
9. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicn producer
10. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant
11. Production of hybrid anthracycline antibiotics by heterogous expression of Streptomyces nogalater nogalamycin biosynthesis genes
12. New anthracycline metabolites produced by aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133
13. Cloning and sequencing of a gene encoding carminomycin 4-O-methyltransferase from Streptomyces peucetius and its expression in Escherichia coli
14. Construction of thiostrepton-inducible, high-copy-number expression vectors for use in Streptomyces spp
15. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline metabolites epelmycins produced by a blocked mutant strain SU2-730
16. New antitumor antibiotics acalcinomycin A and B
17. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptmyces violaceus A262
18. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18
19. Isolation and identification of common intermediate produced by blocked mutants from β-rhodomycin and daunomycin producers
20. Microbial conversion of ε-pyrromycinone and ε-isorhodomycinone to 1-hydroxy-13-dihydrodaunomycin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivites
21. Engineered biosynthesis of novel polyketides: Properties of the whiE aromatase/cyclase
22. The use of antibiotic-producing Streptomycetes for biotrans-formation
23. Polyketide synthesis: Prospects for hybrid antibitics